Can we interrupt the inflammatory signals driving clonal hematopoiesis? Our new study, led by Jayna Mistry, identifies neutrophil-derived S100A8/A9 as a potential therapeutic target to limit DNMT3A-mutant stem cell expansion. doi.org/10.3324/haem...

Show Post

Blood Cancer Awareness Month starts today ❤️ Blood cancer changes everything. Whether you’re living with it, have been through it, supporting someone you love, or remembering someone you’ve lost - this month is for you. Share this to help us raise awareness.

Show Post

Wonderful to see this out - congratulations to co-first authors @magmarlene.bsky.social & @drbmalengier.bsky.social who undertook this comprehensive study while postdocs with Rebecca Gentek at @edinuni-irr.bsky.social, funded by the Kennedy Trust. #macrophage #synovium www.cell.com/cell-reports...

Show Post

Leukaemia UK's annual conference will be back in January 2027, and will be open to all Early Career Researchers from across the UK working on leukaemia. 🔬 🗓️ Save the date: Thursday 28th January 2027 at the Wellcome Collection. More information coming soon!

Show Post

Our funded researchers have uncovered a new way that a key protein helps cancer cells grow and a potential target for future treatments. 💡 🎥 Dr Konstantinos Tzelepis gives us a quick insight into this groundbreaking research. Read more: www.nature.com/articles/s41... @scicambridge.bsky.social

Show Post